Correlation Between Todos Medical and Clene
Can any of the company-specific risk be diversified away by investing in both Todos Medical and Clene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Todos Medical and Clene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Todos Medical and Clene Inc, you can compare the effects of market volatilities on Todos Medical and Clene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Todos Medical with a short position of Clene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Todos Medical and Clene.
Diversification Opportunities for Todos Medical and Clene
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Todos and Clene is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Todos Medical and Clene Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clene Inc and Todos Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Todos Medical are associated (or correlated) with Clene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clene Inc has no effect on the direction of Todos Medical i.e., Todos Medical and Clene go up and down completely randomly.
Pair Corralation between Todos Medical and Clene
If you would invest 532.00 in Clene Inc on August 29, 2025 and sell it today you would earn a total of 483.00 from holding Clene Inc or generate 90.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Todos Medical vs. Clene Inc
Performance |
| Timeline |
| Todos Medical |
| Clene Inc |
Todos Medical and Clene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Todos Medical and Clene
The main advantage of trading using opposite Todos Medical and Clene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Todos Medical position performs unexpectedly, Clene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will offset losses from the drop in Clene's long position.| Todos Medical vs. Fuquan Capital Management | Todos Medical vs. Education Management Corp | Todos Medical vs. Greentown Management Holdings | Todos Medical vs. Bangkok Dusit Medical |
| Clene vs. Natcore Technology | Clene vs. National CineMedia | Clene vs. Glorywin Entertainment Group | Clene vs. Dave Busters Entertainment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |